Heparin-induced thrombocytopenia secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Heparin-induced thrombocytopenia}} {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}, Aric C. Hall, M.D., [mailto:achall@bidmc.harvard.edu] ==Overview== ==Second...")
 
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Heparin-induced thrombocytopenia}}
{{Heparin-induced thrombocytopenia}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}, Aric C. Hall, M.D., [mailto:achall@bidmc.harvard.edu]
{{CMG}}; {{shyam}}


==Overview==
==Overview==
 
There are no secondary prevention measures for HIT.


==Secondary Prevention==
==Secondary Prevention==
There are no secondary prevention measures for HIT.


==Reference==
{{Reflist|2}}


==References==
[[Category:Hematology]]
{{reflist|2}}


[[Category:Drugs]]
{{WS}}
[[Category:Hematology]]
{{WH}}
[[Category:Up-To-Date]]

Latest revision as of 01:36, 31 July 2017

Heparin-induced thrombocytopenia

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Heparin-induced thrombocytopenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Heparin-induced thrombocytopenia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Heparin-induced thrombocytopenia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Heparin-induced thrombocytopenia secondary prevention

CDC on Heparin-induced thrombocytopenia secondary prevention

Heparin-induced thrombocytopenia secondary prevention in the news

Blogs on Heparin-induced thrombocytopenia secondary prevention

Directions to Hospitals Treating Heparin-induced thrombocytopenia

Risk calculators and risk factors for Heparin-induced thrombocytopenia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]

Overview

There are no secondary prevention measures for HIT.

Secondary Prevention

There are no secondary prevention measures for HIT.

Reference

Template:WS Template:WH